LongBio | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

49 results for “LongBio”

Trials

View all 11 →

Efficacy and Safety of TongBi Capsule in Patients With Knee Osteoarthritis

200 participants · First posted Feb 1, 2018

Not yet recruiting

Study of Wenyang Tongbi Formula in the Treatment of Chemotherapy-Induced Polyneuropathy

144 participants · First posted Jun 4, 2026

Not yet recruiting

A Clinical Trial of Longqi Jiangzhi Decoction Against Non-alcoholic Fatty Liver Disease

80 participants · First posted Jan 6, 2026

Drugs

View all 25 →

Anti-IgE humanized antibody (Longbio Pharma)

Biologic; monoclonal antibody; anti-IgE antibody

LP-003

Manufacturer: LongBio Pharma

Conditions: chronic spontaneous urticaria

bi-functional complement antibody-fusion protein

LP-005

Manufacturer: LongBio Pharma

Organizations

Tonghua Dongbao Pharmaceutical Co., Ltd.

China

Kunming Longjin Pharmaceutical Co.,Ltd.

TONGHUA DONGBAO MEDICINES CO., LTD

News

LongBio Pharma Debuts on Hong Kong Stock Exchange at HK$10.7 Billion Valuation, Advancing Novel Anti-IgE and Complement-Targeting Biologics

LongBio's LP-003 Receives IND Approval in China for Food Allergy Treatment

China NMPA Accepts BLA for LongBio's Anti-IgE Antibody LP-003 in Seasonal Allergic Rhinitis

Page 1 of 5